Janus-kinase inhibitors impair the development of antitumor immune responses after radiotherapy and immune checkpoint blockade

被引：0
|
作者：
Gissibl, Julia [1 ]
Timnik, Vincent R. [1 ]
Felchle, Hannah [1 ]
Nefzger, Sophie M. [1 ]
Walther, Caroline N. [1 ]
Combs, Stephanie E. [1 ,2 ]
Fischer, Julius C. [1 ]
机构：
[1] Tech Univ Munich, Klin & Poliklin RadioOnkol & Strahlentherapie, Munich, Germany
[2] Helmholtz Zentrum Munchen, Inst Radiat Med, Munich, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P22-16
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [41] Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
    Liu, Yang
    Dong, Yinping
    Kong, Li
    Shi, Fang
    Zhu, Hui
    Yu, Jinming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [42] Overview of the molecular interactions between radiotherapy and the immune system and immune checkpoint inhibitors
    Melcher, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S177 - S177
  • [43] Combination of immune checkpoint inhibitors and radiotherapy: Review of the literature
    Sindoni, Alessandro
    Minutoli, Fabio
    Ascenti, Giorgio
    Pergolizzi, Stefano
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 113 : 63 - 70
  • [44] Combining Ibrutinib with immune checkpoint blockade to induce therapeutic antitumor immune response in solid tumors
    Sagiv-Barfi, Idit
    Kohrt, Holbrook
    Czerwinski, Debra
    Ng, Patrick
    Chang, Betty
    Levy, Ronald
    CANCER RESEARCH, 2015, 75
  • [45] Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors
    Liu, Wenhui
    Wang, Ying
    Luo, Jianquan
    Liu, Mouze
    Luo, Zhiying
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [46] Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
    House, Imran G.
    Savas, Peter
    Lai, Junyun
    Chen, Amanda X. Y.
    Oliver, Amanda J.
    Teo, Zhi L.
    Todd, Kirsten L.
    Henderson, Melissa A.
    Giuffrida, Lauren
    Petley, Emma V.
    Sek, Kevin
    Mardiana, Sherly
    Gide, Tuba N.
    Quek, Camelia
    Scolyer, Richard A.
    Long, Georgina V.
    Wilmott, James S.
    Loi, Sherene
    Darcy, Phillip K.
    Beavis, Paul A.
    CLINICAL CANCER RESEARCH, 2020, 26 (02) : 487 - 504
  • [47] HDAC inhibitors modulate immune checkpoint blockade in breast cancer
    Barberio, Manuela Terranova
    Thomas, Scott
    Ali, Niwa H.
    Park, Jeenah
    Rosenblum, Michael D.
    Budillon, Alfredo
    Munster, Pamela N.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [48] Combining TNF blockade with immune checkpoint inhibitors in patients with cancer
    Montfort, Anne
    Virazels, Mathieu
    Colacios, Celine
    Meyer, Nicolas
    Segui, Bruno
    NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (09) : 577 - 577
  • [49] Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway
    Hodson, David
    Mistry, Hitesh
    Guzzetti, Sofia
    Davies, Michael
    Staniszewska, Anna
    Farrington, Paul
    Cadogan, Elaine
    Yates, James
    Aarons, Leon
    Ogungbenro, Kayode
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (11): : 1640 - 1652
  • [50] Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
    Huang, Jin-Tao
    Zhong, Bin-Yan
    Jiang, Nan
    Li, Wan-Ci
    Zhang, Shuai
    Yin, Yu
    Yang, Jun
    Shen, Jian
    Wang, Wan-Sheng
    Zhu, Xiao-Li
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 1217 - 1228
12345